With the analysis among 8,574 patents, we discovered top 446 key players by total patent application. Regeneron Pharmaceuticals, Inc., F. Hoffmann-La Roche Ltd., Amgen, Inc. are dominant in this area. They take 4.85% of the total patent filing.
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 148
F. Hoffmann-La Roche Ltd.
California, United States
Patent: 124
Sangamo Therapeutics, Inc.
California, United States
Patent: 116
Sarepta Therapeutics, Inc.
Massachusetts, United States
Patent: 113
Shanghai Biowindow Gene Development Co. Ltd.
Shanghai Shi, China
Patent: 110
Nippon Shinyaku Co., Ltd.
Kyoto-fu, Japan
Patent: 107
The Broad Institute, Inc.
Massachusetts, United States
Patent: 106
National Center of Neurology & Psychiatry
Tokyo-to, Japan
Patent: 97
California, United States
Patent: 84
With the analysis among 499 patents, we discovered top 135 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, Modalis Therapeutics Corp., Ractigen Therapeutics are active in this area.
Institut National de la Santé et de la Recherche Médicale
Modalis Therapeutics Corp.
Tokyo-to, Japan
Patent: 48
Jiangsu Sheng, China
Patent: 22
California, United States
Patent: 14
Encoded Therapeutics, Inc.
California, United States
Patent: 13
California, United States
Patent: 12
Prevail Therapeutics, Inc.
New York, United States
Patent: 12
Massachusetts, United States
Patent: 11
Hrain Biotechnology Co. Ltd.
Shanghai Shi, China
Patent: 11
Fukuoka-ken, Japan
Patent: 10
With the analysis among related 7,916 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing President & Fellows of Harvard College, Regeneron Pharmaceuticals, Inc., The Broad Institute, Inc. take 4.00% of patent filing during this period.
President & Fellows of Harvard College
Massachusetts, United States
Patent: 121
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 101
The Broad Institute, Inc.
Massachusetts, United States
Patent: 95
Nippon Shinyaku Co., Ltd.
Kyoto-fu, Japan
Patent: 71
National Center of Neurology & Psychiatry
Tokyo-to, Japan
Patent: 68
F. Hoffmann-La Roche Ltd.
Regents of the University of California
California, United States
Patent: 59
Sarepta Therapeutics, Inc.
Massachusetts, United States
Patent: 55
California, United States
Patent: 53
Board of Trustees of the Leland Stanford Junior University
California, United States
Patent: 51
With the analysis among related 7,916 patents in last 5 years, we discover 217 new entrants. Modalis Therapeutics Corp., Intellia Therapeutics, Inc., Shenzhen Regis Biotechnology Co., Ltd. are the most active new entrants in this area.
Modalis Therapeutics Corp.
Tokyo-to, Japan
Patent: 48
Intellia Therapeutics, Inc.
Massachusetts, United States
Patent: 38
Shenzhen Regis Biotechnology Co., Ltd.
Guangdong Sheng, China
Patent: 37
Shanghai Shi, China
Patent: 34
Massachusetts, United States
Patent: 22
Jiangsu Sheng, China
Patent: 22
Hangzhou Zheda Dixun Biological Gene Engineering Co., Ltd.
Zhejiang Sheng, China
Patent: 22
Nanjing Qizhen Genetic Engineering Co., Ltd.
Jiangsu Sheng, China
Patent: 21
Jiangsu Sheng, China
Patent: 21
Academy of Military Medical Sciences
With the analysis among 4,492 patents, we discovered top 297 universities and scientific research institutions by total patent application. President & Fellows of Harvard College, Fudan University, Massachusetts Institute of Technology are dominant in this area. They take 8.50% of the total patent filing.
President & Fellows of Harvard College
Massachusetts, United States
Patent: 182
Shanghai Shi, China
Patent: 71
Massachusetts Institute of Technology
Massachusetts, United States
Patent: 64
Washington, United States
Patent: 45
North Carolina, United States
Patent: 43
University of Massachusetts
Massachusetts, United States
Patent: 42
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 42
Shanghai Jiao Tong University
Shanghai Shi, China
Patent: 40
Guangdong Sheng, China
Patent: 38
Zhejiang Sheng, China
Patent: 38